India is rapidly establishing itself as a global hub for neutraceutical active pharmaceutical ingredient manufacturing, driven by a combination of factors including competitive pricing, a skilled personnel, and supportive government regulations. Numerous companies are now focusing on the synthesis and provision of these crucial compounds used in di